Taiwan's Academia Sinica has announced licensing opportunities for rapid screening of the Covid-19 virus antigen.
Academia Sinica, Taiwan's national research academy, says it has synthesized monoclonal antibodies that are able to identify the protein of the virus that causes Covid-19.